Patents Represented by Attorney Joseph F. DePrima
  • Patent number: 5442057
    Abstract: The present invention is directed to a process of making 2-Aryl Carbapenems of Formula 1 from a compound of formula 2.
    Type: Grant
    Filed: April 12, 1994
    Date of Patent: August 15, 1995
    Inventors: Ann Decamp, Ulf H. Dolling, Yulan Li, Dale L. Rieger, Nobuyoshi Yasuda, Lyndon C. Xavier
  • Patent number: 5260332
    Abstract: New Zaragozic acids have been isolated from a culture of MF5465. These compounds and their derivatives are active as squalene synthetase inhibitors and are useful in the treatment of hypercholesterolemia.
    Type: Grant
    Filed: February 7, 1992
    Date of Patent: November 9, 1993
    Assignee: Merci & Co., Inc.
    Inventor: Claude Dufresne
  • Patent number: 5047403
    Abstract: There is disclosed a method for the reduction of a toxicity resulting from the use of nicarbazin in fowl during periods of high heat distress. The method involves the administration of phenothiazine during periods of high ambient temperature and/or relative humidity which are concurrent with periods of nicarbabin treatment. The use of phenothiazine during periods of potential heat induced toxicity caused by the administration of nicarbazin results in reduced mortality, higher feed efficiency and higher weight gain than is observed without the use of phenothiazine.
    Type: Grant
    Filed: August 21, 1989
    Date of Patent: September 10, 1991
    Inventor: Robert G. Teeter
  • Patent number: 4927819
    Abstract: The present invention provides a compound of formula I: ##STR1## or a salt thereof, wherein: the dotted lines represent optional double bonds;R.sup.1 represents hydrogen, hydroxy, alkenyl, alkyl, aminoalkyl or hydroxyalkyl;R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 independently represet hydrogen, hydroxy, fluoro, alkenyl, aryl, alkyl, or alkyl substituted with aryl, amino, hydroxy, carboxy or fluoro; andR.sup.7, R.sup.8, R.sup.9 and R.sup.10 independently represent hydrogen, hydrocarbon or a heterocyclic group provided that R.sup.7, R.sup.8, R.sup.9 and R.sup.10 are not simultaneously hydrogen; orR.sup.7 and R.sup.8 and/or R.sup.9 and R.sup.10 may complete a saturated or unsaturated C.sub.4-9 hydrocarbon or heterocyclic ring; which compounds are useful as anticonvulsant agents and in the treatment and/or prevention of neurodegenerative disorders.
    Type: Grant
    Filed: November 22, 1988
    Date of Patent: May 22, 1990
    Assignee: Merck Sharp & Dohme Limited
    Inventors: Raymond Baker, William R. Carling, Kim James, Paul D. Leeson